View source for PROLONG-II Study

__NOTOC__
{{D-dimer}}

{{CMG}}

==Official Title==


==Objective==


==Sponsor==

==Timeline==
{| class="wikitable" border="1" style="background:WhiteSmoke" width="40%"
|-
| Colspan="2" style="background:Gainsboro" align="center"|'''Timeline'''
|-
| Style="width:30%"| '''Start Date'''||Style="width:70%"| 
|-
| '''Run-In Period'''||
|-
| '''End Date'''||
|-
| '''Status'''||
|-
|}
<span style="font-size:85%">The previous information was derived from ClinicalTrials.gov on 09/20/2013 using the identification number NCT------.</span>

==Study Description==

{| class="wikitable" border="1" style="background:WhiteSmoke" width="40%"
|-
| Colspan="2" style="background:Gainsboro" align="center"|'''Study Description'''
|-
| Style="width:30%"|'''Study Type'''|| Style="width:70%"|
|-
| '''Study Phase''' ||
|-
| Colspan="2" style="background:Gainsboro" align="center"|'''Study Design'''
|-
| '''Allocation'''||
|-
| '''Endpoint'''||
|-
| '''Interventional Model'''||
|-
| '''Masking'''||
|-
| Colspan="2" style="background:Gainsboro" align="center"|'''Study Details'''
|-
| '''Primary Purpose'''||
|-
| '''Condition'''||
|-
| '''Intervention'''||
|-
| '''Study Arms'''||
|-
| '''Population Size'''||
|-
|}

<span style="font-size:85%">The previous information was derived from ClinicalTrials.gov on 09/20/2013 using the identification number NCT-----.</span>

==Eligibility Criteria==
===Inclusion Criteria===

===Exclusion Criteria===

==Outcomes==
===Primary Outcomes===

===Secondary Outcomes===

==Publications==
===Results===

===Conclusion===

==References==
{{Reflist|2}}

[[Category:Laboratory Test]]
[[Category:Chemical pathology]]
[[Category:Hematology]]
[[Category:Fibrinolytic system]]
[[Category:Cardiology]]
[[Category:Pulmonology]]

{{WH}}
{{WS}}